Literature DB >> 18979198

Mitochondrial dysfunction and psychiatric disorders.

Gislaine T Rezin1, Graziela Amboni, Alexandra I Zugno, João Quevedo, Emilio L Streck.   

Abstract

Mitochondrial oxidative phosphorylation is the major ATP-producing pathway, which supplies more than 95% of the total energy requirement in the cells. Damage to the mitochondrial electron transport chain has been suggested to be an important factor in the pathogenesis of a range of psychiatric disorders. Tissues with high energy demands, such as the brain, contain a large number of mitochondria, being therefore more susceptible to reduction of the aerobic metabolism. Mitochondrial dysfunction results from alterations in biochemical cascade and the damage to the mitochondrial electron transport chain has been suggested to be an important factor in the pathogenesis of a range of neuropsychiatric disorders, such as bipolar disorder, depression and schizophrenia. Bipolar disorder is a prevalent psychiatric disorder characterized by alternating episodes of mania and depression. Recent studies have demonstrated that important enzymes involved in brain energy are altered in bipolar disorder patients and after amphetamine administration, an animal model of mania. Depressive disorders, including major depression, are serious and disabling. However, the exact pathophysiology of depression is not clearly understood. Several works have demonstrated that metabolism is impaired in some animal models of depression, induced by chronic stress, especially the activities of the complexes of mitochondrial respiratory chain. Schizophrenia is a devastating mental disorder characterized by disturbed thoughts and perception, alongside cognitive and emotional decline associated with a severe reduction in occupational and social functioning, and in coping abilities. Alterations of mitochondrial oxidative phosphorylation in schizophrenia have been reported in several brain regions and also in platelets. Abnormal mitochondrial morphology, size and density have all been reported in the brains of schizophrenic individuals. Considering that several studies link energy impairment to neuronal death, neurodegeneration and disease, this review article discusses energy impairment as a mechanism underlying the pathophysiology of some psychiatric disorders, like bipolar disorder, depression and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979198     DOI: 10.1007/s11064-008-9865-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  84 in total

1.  Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.

Authors:  I Maurer; S Zierz; H Möller
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

Review 3.  Supramolecular structure of the mitochondrial oxidative phosphorylation system.

Authors:  Egbert J Boekema; Hans-Peter Braun
Journal:  J Biol Chem       Date:  2006-11-13       Impact factor: 5.157

4.  Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome.

Authors:  C A Tamminga; G K Thaker; R Buchanan; B Kirkpatrick; L D Alphs; T N Chase; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1992-07

5.  Increased mitochondrial complex I activity in platelets of schizophrenic patients.

Authors:  Dorit Ben-Shachar; Rosa Zuk; Haifa Gazawi; Alon Reshef; Ala Sheinkman; Ehud Klein
Journal:  Int J Neuropsychopharmacol       Date:  1999-12       Impact factor: 5.176

6.  The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.

Authors:  Haim Einat; Peixiong Yuan; Todd D Gould; Jianling Li; JianHua Du; Lei Zhang; Husseini K Manji; Guang Chen
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

7.  BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents.

Authors:  Lian Mai; Richard S Jope; Xiaohua Li
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

9.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

10.  Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder.

Authors:  Tatiana Perova; Michael J Wasserman; Peter P Li; Jerry J Warsh
Journal:  Int J Neuropsychopharmacol       Date:  2007-08-06       Impact factor: 5.176

View more
  131 in total

1.  Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment.

Authors:  Bárbara Tagliari; Cristie G Noschang; Andréia G K Ferreira; Otávio A Ferrari; Luciane R Feksa; Clovis M D Wannmacher; Carla Dalmaz; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-05-27       Impact factor: 3.584

2.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

3.  Diagnosis of mitochondrial disorders applying massive pyrosequencing.

Authors:  Marcelo Andrés Kauffman; Dolores Gonzlez-Morón; Damián Consalvo; Gastón Westergaard; Martín Vazquez; Estefanía Mancini; Ana Lía Taratuto; Raúl Rey; Silvia Kochen
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

4.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

5.  Pinocembrin Suppresses H2O2-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells.

Authors:  Marcos Roberto de Oliveira; Gustavo da Costa Ferreira; Flávia Bittencourt Brasil; Alessandra Peres
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

6.  Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression.

Authors:  Kim Henningsen; Johan Palmfeldt; Sofie Christiansen; Isabel Baiges; Steffen Bak; Ole Nørregaard Jensen; Niels Gregersen; Ove Wiborg
Journal:  Mol Cell Proteomics       Date:  2012-02-06       Impact factor: 5.911

7.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

Review 8.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

9.  Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress.

Authors:  Gaurav Patki; Naimesh Solanki; Fatin Atrooz; Farida Allam; Samina Salim
Journal:  Brain Res       Date:  2013-10-03       Impact factor: 3.252

10.  iTRAQ-Based Quantitative Proteomics Suggests Synaptic Mitochondrial Dysfunction in the Hippocampus of Rats Susceptible to Chronic Mild Stress.

Authors:  Hong Xie; Haojun Huang; Min Tang; Yan Wu; Rongzhong Huang; Zhao Liu; Mi Zhou; Wei Liao; Jian Zhou
Journal:  Neurochem Res       Date:  2018-10-22       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.